Conatus Pharmaceuticals Inc. Credit Rating

BOSTON (AI Credit Rating Terminal) Wed Jul 22 2020 21:19:02 GMT+0000 (Coordinated Universal Time) AI Credit Ratings today took the rating actions below:

Rating Action Overview


We downgraded Conatus Pharmaceuticals Inc. because the steps to carry out a bail-in of that type of liability would involve such high operational complexities that would make its bail-in unlikely in a reasonable time. We use econometric methods for period (n+7) simulate with Speculation Ridge Regression. Reference code is: 4409. Beta DRL value REG 40 Rational Demand Factor LD 4611.3606. When evaluating uses of liquidity, we include all debt maturities over the liquidity horizon that are either recourse to the company, or nonrecourse that we believe the company will support even in times of stress. In cases where the debt includes a put option held by debtholders, we will consider the date of the put option the effective debt maturity--i.e., we will assume the debt will need to be repaid/refinanced on the day the put can be first exercised. Credit Rating AI Process rely on primary sources of information: Sec Filings, Financial Statements, Credit Ratings, Semantic Signals. Take a look at Machine Learning section for Financial Deep Reinforcement Learning.Oscillators are used for generating credit risk signals by using the semantic and financial signals. The value of the oscillators indicate the strength of trend. Using the correlation matrices, the credit rating risk map for Conatus Pharmaceuticals Inc. as below:

Credit Ratings for Conatus Pharmaceuticals Inc. as of 22 Jul 2020


Credit Rating Short-Term Long-Term Senior
AI Rating Class*B2Baa2
Semantic Signals5485
Financial Signals7175
Risk Signals5176
Substantial Risks6079
Speculative Signals3862

*Machine Learning utilizes multiple learning algorithms to obtain better predictive powers. In our research, we utilize machine learning to combine the results from the Neural Network and Support Vector Machines.
We work across the world

From London to San Francisco, to our home base in (Saint Helier) Jersey, we’re looking for extraordinary and creative scientists to help us drive the field forward.

Disclaimers: AC Investment Inc. currently does not act as an equities executing broker or route orders containing equities securities. All data and information is provided “as is” for personal informational purposes only, and is not intended for trading purposes or advice. Please consult your broker or financial representative to verify pricing before executing any trade.

77 Massachusetts Avenue Cambridge, MA 02139 617-253-1000 pr@ademcetinkaya.com